Abstract:Abstract Background Takayasu’s arteritis (TAK) is a chronic inflammatory disease characterized by macrophage infiltration. During the active stage, aorta adventitial fibroblasts (AAFs) proliferate excessively and produce numerous pro-inflammatory factors in the adventitia, the primary target of TAK therapy. Although the monocyte chemokine, CCL2, may contribute to macrophage infiltration in TAK arteries, whether there is an associated relationship with HSP65 remains unknown. Moreover, there are no reports of the activation of AAFs to produce inflammatory factors involvement in TAK pathogenesis. TAK treatment is associated with several challenges and contradictions. Curcumin is a traditional Chinese medicine with anti-inflammatory effects; however, its effectiveness for TAK and the underlying mechanism remains unclear. Methods We first verified high HSP65 expression in the aortic adventitia of TAK patients by IHC. mRNA-seq was used to profile differentially expressed genes (DEGs) between AAFs stimulated by HSP65 with or without pretreatment with curcumin, and untreated AAFs. The key chemokine, CCL2, screened by mRNA-seq was detected in the adventitia of the TAK aorta, and its correlation with HSP65 expression was analyzed by double-labelled immunofluorescence. We subsequently explored how HSP65 affected the production of inflammatory factors by AAFs at a cellular level and the related signaling pathway. We explored whether curcumin could hinder this process and verified the effect of curcumin on the level of serum CCL2 in patients with TAK. Results HSP65 was highly expressed in the adventitia of TAK arteries. The DEG analysis showed a key role of CCL2. The expression of CCL2 in the adventitia of TAK arteries was significantly higher than that of healthy subjects, and was correlated with HSP65. HSP65 facilitated the production of CCL2, IL-6, and IL-1β by AAFs via activation of the TLR4-JAK2/AKT/STAT3 pathway, among which the change in CCL2 was the greatest. Curcumin treatment reversed HSP65-induced CCL2 upregulation in vitro, which was more obvious than that of MTX and tofacitinib. Finally, curcumin significantly downregulated the level of serum CCL2 in TAK patients. Conclusion HSP65 initiates and promotes TAK inflammation by upregulating CCL2 in AAFs through the JAK2/AKT/STAT3 pathway, whereas curcumin could reverse this process and slow the initiation and development of TAK.

Curcumin relieves TPA-induced Th1 inflammation in K14-VEGF transgenic mice

Curcumin shows excellent therapeutic effect on psoriasis in mouse model

Curcumin’s Metabolites, Tetrahydrocurcumin and Octahydrocurcumin, Possess Superior Anti-inflammatory Effects in vivo Through Suppression of TAK1-NF-κB Pathway

TPA induction leads to a Th17-like response in transgenic K14/VEGF mice: a novel in vivo screening model of psoriasis

Curcumin Alleviates Inflammation in Takayasu's Arteritis by Blocking CCL2 Overexpression in Adventitial Fibroblasts

Therapeutic potential of a triazole curcumin in inflammation: Decreased LPS-induced acute lung injury in mice by targeting MD2/TLR4

Therapeutic value of curcumin on the initiation and development of inflammation in Takayasu’s arteritis mediated by HSP65-induced CCL2 overexpression

Regulatory T cells control VEGF-dependent skin inflammation

Anti-inflammatory Effects of Curcumin in Microglial Cells

GW24-e1159 Curcumin Inhibits LPS-induced Inflammation in Rat Vascular Smooth Muscle Cells in Vitro Via ROS-relative TLR4-MAPK/NF-κB Pathways

[Effect of Triptolide on TNFalpha-induced Activation of NF-kappaB and Expression of COX-2 and Inos in Human Rheumatoid Arthritis Synovial Fibroblasts].

Curcumin alleviates rheumatoid arthritis progression through the phosphatidylinositol 3-kinase/protein kinase B pathway: an in vitro and in vivo study

Anti-inflammatory effect of combined tetramethylpyrazine, resveratrol and curcumin in vivo

Curcuma's extraction attenuates propranolol-induced psoriasis like in mice by inhibition of keratin, proliferating cell nuclear antigen and toll-like receptor expression.

Curcumin alleviates LPS-induced retinal inflammation by inhibiting PI3k/Akt signaling pathway

Curcumin Inhibits LPS-induced Inflammation in Rat Vascular Smooth Muscle Cells in Vitro Via ROS-relative TLR4-MAPK/NF-κB Pathways.

Curcumin Modulates Macrophage Polarization Through the Inhibition of the Toll-Like Receptor 4 Expression and Its Signaling Pathways

Antiinflammatory Effect of Curcumin on Experimental Colitis in Rats via Peroxisome Proliferator-activated Receptor-γ

Curcumin alleviates imiquimod-induced psoriasis-like inflammation and regulates gut microbiota of mice

Curcumin alleviates LPS-induced inflammation and oxidative stress in mouse microglial BV2 cells by targeting miR-137-3p/NeuroD1

Curcumin exerts anti-inflammatory and antioxidative properties in 1-methyl-4-phenylpyridinium ion (MPP+)-stimulated mesencephalic astrocytes by interference with TLR4 and downstream signaling pathway